Capricor Therapeutics Inc(CAPR)

盘后13.100.03+0.23%19:59 EST

13.07+0.17+1.32%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
暂无内容
公司概况
公司名称
Capricor Therapeutics Inc
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.capricor.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Capricor Therapeutics, Inc.在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，专注于开发转化细胞和外泌体疗法，用于治疗Duchenne肌营养不良症（DMD），这是一种罕见的肌肉营养不良症，会导致肌肉退化和过早死亡，以及医疗需求未得到满足的疾病。自成立以来，该公司投入了大量资源开发CAP-1002和候选产品，包括外泌体平台，开发制造流程，为公司配备人员，并为这些业务提供行政支持。该公司没有任何获准销售的产品。公司能否最终产生足以实现盈利的任何产品收入，将取决于用于治疗DMD和其他候选产品的CAP-1002的成功开发、批准和最终商业化。
- 11-15
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 11-13
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 11-08
  超过5%披露
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 11-07
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 10-17
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 10-17
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 10-16
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 10-16
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 10-09
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 09-24
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 09-24
  超过5%披露
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 09-17
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report
- 08-23
  超过5%披露
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
  Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
- 08-08
  季度报告
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
  Form 10-Q - Quarterly report [Sections 13 or 15(d)]
- 08-07
  重要事件披露
  Form 8-K - Current report
  Form 8-K - Current report